Results 161 to 170 of about 12,197 (223)

Outbreak of poisoning by sodium hydrogen methylarsonate (MSMA)—an arsenic‐based herbicide—in horses in Brazil

Equine Veterinary Journal, EarlyView.
Abstract Background Arsenic poisoning in horses is rarely reported in the literature. However, arsenic compounds can be present in rodenticides, pesticides, and herbicides, representing a potential source of accidental exposure for horses. Objective To describe the epidemiological, clinical, and laboratory findings from a herd of 31 horses exposed to ...
Gabriella Faria Pereira, Maria Clara Hornich Blimbliem, Anna Laura Previato Rosa Machado, Junara Bianca Rosa Abdala, Geison Morel Nogueira, Hugo Shisei Toma, Tatiane Furtado de Carvalho, Diego José Zanzarini Delfiol   +7 more
wiley   +1 more source

Bringing Gene Therapy Into Real World Clinical Practice

Haemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach, Pratima Chowdary, Margareth C. Ozelo   +2 more
wiley   +1 more source

Post-miscarriage Complement-Mediated Thrombotic Microangiopathy in a 27-Year-Old Woman: A Case Highlighting Diagnostic and Therapeutic Gaps in Brazil. [PDF]

Cureus
Torres FBO, Souza Santos LO, Chagas Pereira NL, Uchôa Xavier Rodrigues LS, Santana de Oliveira JL.   +4 more
europepmc   +1 more source

Performing Large‐Scale Genetic Analysis in the Bleeding Disorders Community

Haemophilia, EarlyView.
ABSTRACT Inherited bleeding disorders encompass a diverse group of conditions caused by genetic defects affecting coagulation factors, fibrinogen, von Willebrand factor, or platelet function. Despite major advances in quantitative and functional laboratory assays, a substantial diagnostic gap remains, particularly in patients with mild or atypical ...
Anna R. Blankstein, Sterre P. E. Willems, Saskia E. M. Schols, Rosanna Asselta, Gillian Lowe, Neil V. Morgan, Paula D. James   +6 more
wiley   +1 more source

Maternal Outcomes Associated with Delayed Cord Clamping in Hypertensive Disorders of Pregnancy: A Cross-Sectional Study. [PDF]

Diseases
Turekulova A, Dzhardemaliyeva N, Rabe H, Kulimbet M.   +3 more
europepmc   +1 more source

Rare Bleeding Disorders and Bleeding Disorder of Unknown Cause: Current Understanding and Recent Developments

Haemophilia, EarlyView.
ABSTRACT Rare bleeding disorders (RBDs) represent a diverse group of inherited conditions involving coagulation factors or platelets. These conditions, such as Glanzmann thrombasthenia (GT) or severe coagulation factor deficiencies, are uncommon. In contrast, bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion without an identifiable ...
Alessandro Casini, Robert Klamroth, Bauke Haisma, Dino Mehic, Saskia E. M. Schols   +4 more
wiley   +1 more source

Health‐Related Quality of Life Among Female Carriers of Haemophilia and Non‐Carriers in a Colombian Population

Haemophilia, EarlyView.
ABSTRACT Introduction Women with haemophilia can present manifestations and experience undiagnosed symptoms, which negatively affect their health‐related quality of life (HRQoL). Objective To evaluate the HRQoL in obligate carriers of haemophilia (OCH) versus women non‐carriers of haemophilia (WNCH) in a Colombian population.
Fabian A. Manzano‐Di Zeo, Claudia Sossa‐Melo, Maria Luna‐Gonzalez, Miguel Ochoa‐Vera, Melanie Tarazona‐Bohórquez, Luis A. Salazar‐Montaña, Luisa Sánchez‐Sossa, Katherinee Morales‐Chacón, Juan José Rey‐Serrano, Angela M. Peña‐Castellanos   +9 more
wiley   +1 more source

Treatment outcomes of acute leukemia during pregnancy at the National Institute of Hematology and Blood Transfusion. [PDF]

Leuk Res Rep
Khanh BQ, Son NH, Nhat NQ, Thuy TT, Huong NTM, Chang NT, Thanh NH.   +6 more
europepmc   +1 more source

Real‐World Use of Emicizumab in Patients With Acquired Haemophilia A: An Interim Safety Analysis of a Large‐Scale Post‑Marketing Surveillance Study

Haemophilia, EarlyView.
ABSTRACT Introduction Acquired haemophilia A (AHA) is a rare autoimmune disorder where the development of autoantibodies to factor (F)VIII neutralise its function, leading to bleeding. Emicizumab has been approved for treating AHA in Japan. Aim This post‐marketing study was performed to primarily examine the use and safety of emicizumab, and indirectly
Midori Shima, Katsuyuki Fukutake, Yoshiyuki Ogawa, Yuta Kamei, Chiaki Sugita, Akinori Yuri, Ryota Kobayashi, Akiko Ioka, Tadashi Matsushita   +8 more
wiley   +1 more source

Pregnancy After <i>In Vitro</i> Fertilization in Budd-Chiari Syndrome Secondary to Polycythemia Vera: Multidisciplinary Management and Perioperative Considerations. [PDF]

J Med Cases
Musulin N, Krofak S, Jokic A, Kolarek IP, Pavlovic M, Bekavac Vlatkovic I.   +5 more
europepmc   +1 more source